SCHEMBL24631145

SCHEMBL24631145

CNS(=O)(=O)c1ccc(Oc2ccc(C(F)(F)F)cn2)c(-c2cn3c(n2)CCC3)c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 1/20 0.40
▸ YAP1 P46937 1/20 0.40
▸ SCN9A Q15858 6/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ USP30 Q70CQ3 3/20 0.37
▸ UCHL1 P09936 2/20 0.37
▸ TNNI3K Q59H18 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ POLB P06746 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ LIPE Q05469 1/20 0.35
▸ WDR5 P61964 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29814077 0.88 TEAD1 (0.42) TEAD1YAP1SCN9ATNNI3KMEN1
SCHEMBL24631107 0.88 TEAD1 (0.42) TEAD1YAP1SCN9ATNNI3KMEN1
SCHEMBL27170923 0.85 TEAD1 (0.42) TEAD1YAP1SCN9AMEN1LMNA
SCHEMBL24631244 0.85 BRD4 (0.40) TEAD1YAP1SCN9ATNNI3KLMNA
SCHEMBL30868581 0.84 BRD4 (0.41) TEAD1YAP1L3MBTL1MEN1LMNA
SCHEMBL27170897 0.84 BRD4 (0.41) TEAD1YAP1L3MBTL1MEN1LMNA
SCHEMBL24879863 0.82 TEAD1 (0.51) TEAD1YAP1TNNI3KMAPT
SCHEMBL24631206 0.82 WDR5 (0.40) TEAD1YAP1LMNAKMT2ASMN1; SMN2
SCHEMBL30114160 0.80 TEAD1 (0.50) TEAD1YAP1TNNI3KMAPT
SCHEMBL24879883 0.80 TEAD1 (0.50) TEAD1YAP1TNNI3KMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240083903-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS MERCK SHARP & DOHME LLC (US) 2024-03-14 — — US disclosed
EP-4294382-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS Merck Sharp & Dohme LLC (US) 2023-12-27 — — EP disclosed
WO-2022177869-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS MERCK SHARP & DOHME LLC (US) 2022-08-25 — — WO disclosed
WO-2022177869-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS MERCK SHARP & DOHME LLC (US) 2022-08-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083903-A1 ARYL ETHER COMPOUNDS AS TEAD MODULATORS TEAD2, TEAD3, TEAD4 TEAD1 4/4885YAP1 176/4885SCN9A 353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback